Archive for Medication updates
Drug Tariff News – December Part VIIIA reimbursement prices (issued 15 December)
Source: NHSBSA / DHSC The Department of Health and Social Care has agreed the December Drug Tariff Part VIIIA reimbursement prices for the following items: Amisulpride 50mg tablets 60 £2.99 Co-dydramol 10mg/500mg...
CQC to postpone inspections of acute hospitals and general practice until New Year to support acceleration of booster programme
Source: CQC The acceleration of the vaccine booster programme, announced yesterday in response to alarming new data about the spread of the Omicron variant, will require a massive effort from...
Class 2 Medicines Recall: Novartis Pharmaceuticals UK, Lucentis 10 mg/ml solution for injection in pre-filled syringe EL (21)A/36
Source: MHRA Gov.uk Novartis Pharmaceuticals UK are recalling the above batch due to a faulty plunger stopper which has led to an increased number of customer complaints relating to the...
MIMS introduces leaf symbol to support sustainable inhaler prescribing
Source: MIMS 8/12/21 A leaf symbol now appears in the print issue of MIMS to highlight inhalers with a lower carbon footprint. From December, the listings for dry powder...
Class 2 Medicines Recall: Intrapharm Laboratories Ltd, Mydrilate 0.5% Eye Drops 5ml, EL (21)A/35
Source: MHRA Gov.uk 8.12.21 Intrapharm Laboratories Ltd are recalling the above batch of Mydrilate 0.5 % Eye Drops 5ml as a precautionary measure due to out of specification results for...
Greener Inhaled Corticosteroids
By Dr Philip Koopowitz Some corticosteroid inhalers contain propellants, known as hydrofluorocarbons (HFCs). HFCs do not have an effect on the ozone layer. However, they are powerful greenhouse gases and...
Parallel Import Profitability – December Update!
We have updated the Parallel Import Profitability tool with the latest December prices!!! Dispex Member can gain access to our Profitability Tools and data. We provide everything you need to help...
Class 2 Medicines Recall: Various Marketing Authorisation Holders and parallel distributor companies, Irbesartan-containing products, EL(21)A/34
Source: MHRA Gov.uk 1/12/21 Specific batches of products supplied by Marketing Authorisation Holders and parallel distributor companies are being recalled due to presence of a mutagenic impurity. MDR Number MDR...
Class 2 Medicines Recall: Various Marketing Authorisation Holders and parallel distributor companies, Irbesartan-containing products, EL(21)A/34
Source: MHRA Gov.uk 30.11.21 Specific batches of products supplied by Marketing Authorisation Holders and parallel distributor companies are being recalled due to presence of a mutagenic impurity. MDR Number MDR...
Class 4 Medicines Defect Information: Mometasone Furoate 50 Microgram / Dose Nasal Spray, Suspension, PilsCo Ltd, EL (21)A/33
Source: MHRA Gov.uk 29.11.21 Error relating to the wording on the outer carton label for Mometasone Furoate 50 Microgram / Dose Nasal Spray, supplied by PilsCo Ltd. MDR Number...
Class 4 Medicines Defect Information: Diuril Oral Solution (unlicensed medicine), Mawdsley-Brooks & Company Limited, EL (21)A/32
Source: MHRA Gov.uk 29.11.21 Error with the patient information leaflet (PIL) that has been provided with Diuril Oral Solution, supplied by Mawdsley-Brooks & Company Limited. MDR Number MDR 241-11/21 Company...
Drug Tariff News – November Part VIIIA reimbursement prices (issued 26 November)
Source: NHSBSA The Department of Health and Social Care has agreed the November Drug Tariff Part VIIIA reimbursement prices for the following items: Amisulpride 50mg tablets 60 £2.99 Donepezil 1mg/ml oral solution...
